Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 31 → 32·13:16, 13 Jun 2025
Difference between revision 31 and revision 32 of Shanghai Wibson Biotechnology. 1 line changed; the page grew by 103 bytes.
| Revision 31 — 02:45, 8 Jun 2025 TFA_Counterion (talk) rv addition of price information per PP:VN 6,815 bytes ±0 | Revision 32 — 13:16, 13 Jun 2025 TallySheetTad (talk) add citation for the incidence figure 6,918 bytes +103 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Notability with a five-year history and no independent coverage}} | |
| 21 | 22 | ||
| 22 | '''Shanghai Wibson Biotechnology Co., Ltd.''' (trading as '''SWB'''; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} | 23 | '''Shanghai Wibson Biotechnology Co., Ltd.''' (trading as '''SWB'''; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} |